Many studies have demonstrated that manipulating miRNA expression might enhance the efficacy of mutant p53 proteins in several types of cancer, such as breast cancer, non-small cell lung carcinoma (NSCLC), and HNSCC [4]. This evidence concerns the gene TP53 and non-small cell lung carcinoma.